Skip to main content
Erschienen in: Neuroradiology 3/2015

01.03.2015 | Paediatric Neuroradiology

Relative cerebral blood volume from dynamic susceptibility contrast perfusion in the grading of pediatric primary brain tumors

verfasst von: Chang Y. Ho, Jeremy S. Cardinal, Aaron P. Kamer, Stephen F. Kralik

Erschienen in: Neuroradiology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The aim of this study is to evaluate the utility of relative cerebral blood volume (rCBV) data from dynamic susceptibility contrast (DSC) perfusion in grading pediatric primary brain tumors.

Methods

A retrospective blinded review of 63 pediatric brain tumors with DSC perfusion was performed independently by two neuroradiologists. A diagnosis of low- versus high-grade tumor was obtained from conventional imaging alone. Maximum rCBV (rCBVmax) was measured from manual ROI placement for each reviewer and averaged. Whole-tumor CBV data was obtained from a semi-automated approach. Results from all three analyses were compared to WHO grade.

Results

Based on conventional MRI, the two reviewers had a concordance rate of 81 % (k = 0.62). Compared to WHO grade, the concordant cases accurately diagnosed high versus low grade in 82 %. A positive correlation was demonstrated between manual rCBVmax and tumor grade (r = 0.30, P = 0.015). ROC analysis of rCBVmax (area under curve 0.65, 0.52–0.77, P = 0.03) gave a low-high threshold of 1.38 with sensitivity of 92 % (74–99 %), specificity of 40 % (24–57 %), NPV of 88 % (62–98 %), and PPV of 50 % (35–65 %) Using this threshold on 12 discordant tumors between evaluators from conventional imaging yielded correct diagnoses in nine patients. Semi-automated analysis demonstrated statistically significant differences between low- and high-grade tumors for multiple metrics including average rCBV (P = 0.027).

Conclusions

Despite significant positive correlation with tumor grade, rCBV from pediatric brain tumors demonstrates limited specificity, but high NPV in excluding high-grade neoplasms. In selective patients whose conventional imaging is nonspecific, an rCBV threshold may have further diagnostic value.
Literatur
1.
Zurück zum Zitat Law M, Yang S, Wang H et al (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24:1989–1998PubMed Law M, Yang S, Wang H et al (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24:1989–1998PubMed
2.
Zurück zum Zitat Bulakbasi N, Kocaoglu M, Farzaliyev A et al (2005) Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors. AJNR Am J Neuroradiol 26:2187–2199PubMed Bulakbasi N, Kocaoglu M, Farzaliyev A et al (2005) Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors. AJNR Am J Neuroradiol 26:2187–2199PubMed
3.
Zurück zum Zitat Law M, Young R, Babb J et al (2007) Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR Am J Neuroradiol 28:761–766PubMed Law M, Young R, Babb J et al (2007) Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR Am J Neuroradiol 28:761–766PubMed
4.
Zurück zum Zitat Shin J, Lee H, Kwun B et al (2002) Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. Am J Roentgenol 179:783–789CrossRef Shin J, Lee H, Kwun B et al (2002) Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. Am J Roentgenol 179:783–789CrossRef
5.
Zurück zum Zitat Law M, Young R, Babb J et al (2006) Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 27:1975–1982PubMed Law M, Young R, Babb J et al (2006) Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 27:1975–1982PubMed
6.
Zurück zum Zitat Fan G, Deng Q, Wu Z, Guo Q (2006) Usefulness of diffusion/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumour grading? Br J Radiol 79:652–658CrossRefPubMed Fan G, Deng Q, Wu Z, Guo Q (2006) Usefulness of diffusion/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumour grading? Br J Radiol 79:652–658CrossRefPubMed
7.
Zurück zum Zitat Morita N, Wang S, Chawla S et al (2010) Dynamic susceptibility contrast perfusion weighted imaging in grading of nonenhancing astrocytomas. J Magn Reson Imaging 32(4):803–808CrossRefPubMed Morita N, Wang S, Chawla S et al (2010) Dynamic susceptibility contrast perfusion weighted imaging in grading of nonenhancing astrocytomas. J Magn Reson Imaging 32(4):803–808CrossRefPubMed
8.
Zurück zum Zitat Boxerman J, Schmainda K, Weisskoff R (2006) Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 27:859–67PubMed Boxerman J, Schmainda K, Weisskoff R (2006) Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 27:859–67PubMed
9.
Zurück zum Zitat Ball W Jr, Holland S (2001) Perfusion imaging in the pediatric patient. Magn Reson Imaging Clin N Am 9:207–230PubMed Ball W Jr, Holland S (2001) Perfusion imaging in the pediatric patient. Magn Reson Imaging Clin N Am 9:207–230PubMed
11.
Zurück zum Zitat Koeller K, Rushing E (2004) From the archives of the AFIP: pilocytic astrocytoma: radiologic-pathologic correlation. Radiographics 24:1693–1708CrossRefPubMed Koeller K, Rushing E (2004) From the archives of the AFIP: pilocytic astrocytoma: radiologic-pathologic correlation. Radiographics 24:1693–1708CrossRefPubMed
12.
Zurück zum Zitat Brat D, Scheithauer B, Fuller G, Tihan T (2007) Newly codified glial neoplasms of the 2007 WHO classification of tumours of the central nervous system: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain Pathol 17:319–324CrossRefPubMed Brat D, Scheithauer B, Fuller G, Tihan T (2007) Newly codified glial neoplasms of the 2007 WHO classification of tumours of the central nervous system: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain Pathol 17:319–324CrossRefPubMed
13.
Zurück zum Zitat Lev M, Ozsunar Y, Henson J et al (2004) Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol 25:214–221PubMed Lev M, Ozsunar Y, Henson J et al (2004) Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol 25:214–221PubMed
14.
Zurück zum Zitat Xu M, See S, Ng W et al (2005) Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Neurosurgery 56:919–926PubMed Xu M, See S, Ng W et al (2005) Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Neurosurgery 56:919–926PubMed
15.
Zurück zum Zitat Kool M, Korshunov A, Remke M et al (2012) Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, group 3, and group 4 medulloblastomas. Acta Neuropathol 123(4):473–84. doi:10.1007/s00401-012-0958-8 CrossRefPubMedCentralPubMed Kool M, Korshunov A, Remke M et al (2012) Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, group 3, and group 4 medulloblastomas. Acta Neuropathol 123(4):473–84. doi:10.​1007/​s00401-012-0958-8 CrossRefPubMedCentralPubMed
16.
Zurück zum Zitat Cha S (2006) Dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in pediatric patients. Neuroimaging Clin N Am 16(1):137–147CrossRefPubMed Cha S (2006) Dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in pediatric patients. Neuroimaging Clin N Am 16(1):137–147CrossRefPubMed
17.
Zurück zum Zitat Grand S, Kremer S, Tropres I et al (2007) Perfusion-sensitive MRI of pilocytic astrocytomas: initial results. Neuroradiology 49(7):545–550CrossRefPubMed Grand S, Kremer S, Tropres I et al (2007) Perfusion-sensitive MRI of pilocytic astrocytomas: initial results. Neuroradiology 49(7):545–550CrossRefPubMed
19.
Zurück zum Zitat Sentürk S, Oğuz K, Cila A (2009) Dynamic contrast enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3 T MR scanner. Diagn Interv Radiol 15:3–12PubMed Sentürk S, Oğuz K, Cila A (2009) Dynamic contrast enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3 T MR scanner. Diagn Interv Radiol 15:3–12PubMed
20.
Zurück zum Zitat Lev MH, Rosen BR (1999) Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin N Am 9:309–331PubMed Lev MH, Rosen BR (1999) Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin N Am 9:309–331PubMed
21.
Zurück zum Zitat Darpolor MM, Molthen RC, Schmainda KM (2011) Multimodality imaging of abnormal vascular perfusion and morphology in preclinical 9L gliosarcoma model. PLoS One 6(1):e16621CrossRefPubMedCentralPubMed Darpolor MM, Molthen RC, Schmainda KM (2011) Multimodality imaging of abnormal vascular perfusion and morphology in preclinical 9L gliosarcoma model. PLoS One 6(1):e16621CrossRefPubMedCentralPubMed
22.
Zurück zum Zitat Quarles CC, Krouwer HG, Rand SD, Schmainda KM (2005) Dexamethasone normalizes brain tumor hemodynamics as indicated by dynamic susceptibility contrast MRI perfusion parameters. Technol Cancer Res Treat 4(3):245–9CrossRefPubMed Quarles CC, Krouwer HG, Rand SD, Schmainda KM (2005) Dexamethasone normalizes brain tumor hemodynamics as indicated by dynamic susceptibility contrast MRI perfusion parameters. Technol Cancer Res Treat 4(3):245–9CrossRefPubMed
23.
Zurück zum Zitat Wilkinson ID, Jellineck DA, Levy D et al (2006) Dexamethasone and enhancing solitary cerebral mass lesions: alterations in perfusion and blood-tumor barrier kinetics shown by magnetic resonance imaging. Neurosurgery 58(4):640–6CrossRefPubMed Wilkinson ID, Jellineck DA, Levy D et al (2006) Dexamethasone and enhancing solitary cerebral mass lesions: alterations in perfusion and blood-tumor barrier kinetics shown by magnetic resonance imaging. Neurosurgery 58(4):640–6CrossRefPubMed
24.
Zurück zum Zitat Armitage PA, Schwindack C, Bastin ME, Whittle IR (2007) Quantitative assessment of intracranial tumor response to dexamethasone using diffusion, perfusion and permeability magnetic resonance imaging. Magn Reson Imaging 25(3):303–10CrossRefPubMed Armitage PA, Schwindack C, Bastin ME, Whittle IR (2007) Quantitative assessment of intracranial tumor response to dexamethasone using diffusion, perfusion and permeability magnetic resonance imaging. Magn Reson Imaging 25(3):303–10CrossRefPubMed
25.
Zurück zum Zitat Bastin ME, Carpenter TK, Armitage PA et al (2006) Effects of dexamethasone on cerebral perfusion and water diffusion in patients with high-grade glioma. AJNR Am J Neuroradiol 27(2):402–8PubMed Bastin ME, Carpenter TK, Armitage PA et al (2006) Effects of dexamethasone on cerebral perfusion and water diffusion in patients with high-grade glioma. AJNR Am J Neuroradiol 27(2):402–8PubMed
Metadaten
Titel
Relative cerebral blood volume from dynamic susceptibility contrast perfusion in the grading of pediatric primary brain tumors
verfasst von
Chang Y. Ho
Jeremy S. Cardinal
Aaron P. Kamer
Stephen F. Kralik
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Neuroradiology / Ausgabe 3/2015
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-014-1478-0

Weitere Artikel der Ausgabe 3/2015

Neuroradiology 3/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.